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Abstract
Background Injuries of the recurrent laryngeal nerve with
consecutive vocal cord paralysis is a typical complication in
chest, esophageal, thyroideal, and neck surgery. Glottic
insufficiency secondary to such a lesion can be treated by
endolaryngeal vocal cord augmentation (injection laryngo-
plasty). Many different substances have been used, often
showing complications or disadvantages. This study reports
on the use of injectable polydimethylsiloxane (PDMS), with
special regard to the long-term results.
Methods In this prospective study, 21 patients with unilat-
eral vocal cord paralysis underwent injection laryngoplasty
using PDMS at a volume of 0.5–1.0 ml. Preoperatively, 6
weeks and 12 months after the injection the following
parameters concerning patients’ voice were evaluated: Glottic
closure by videolaryngostroboscopy, maximum phonation
time, voice range, voice dynamic, jitter, shimmer, noise-to-
harmonic-ratio, and roughness, breathiness, and hoarseness
(RBH). In addition, patients were asked to give their own
evaluation of how satisfied they felt with their voice and of the
handicaps it caused them.
Results Postoperatively an improvement was evident in
all the parameters that were investigated, and this signifi-
cant improvement was still in evidence for most of the
parameters more than one year after the injection. In our
study no complications were observed more than one year
after injection.
Conclusion PDMS is a safe substance for injection
laryngoplasty in unilateral vocal cord paresis. Objective
and subjective parameters confirm its effectiveness. It is
suitable for obtaining satisfying results in the reestablish-
ment of the patient’s voice and communication ability.
Introduction
Lesions of the recurrent laryngeal nerve leading to a vocal
fold paralysis occur not only in neck surgery, but they also
are typical complications in chest, cardial, esophageal, and
endocrine surgery. Unilateral vocal fold paralysis can
remain asymptomatic if glottic closure or near glottic
closure is achieved by a compensatory movement of the
contralateral vocal fold. If this does not happen spontane-
ously, compensation can be induced by voice therapy.
However, some patients undergoing voice therapy do not
succeed in compensating. The voice then remains breathy,
rough, and weak, often lacking resonance. Other patients
want to achieve a normal voice within a short time. In these
cases therapy focuses on medialization of the paralyzed
vocal fold to achieve sufficient glottic closure. In these
patients injection laryngoplasty is a safe and easy method.
Since its introduction 1911 by Bru¨ning (cited as quoted in
[1]), a range of substances such as paraffin, autologous fat
tissue, fascia, gelatin, calcium hydroxylapatite, hyaluronan
acid, and Teflon has been tried and most of them were
abandoned due to resorption, migration, or complications
[2, 3].
A promising substance is polydimethylsiloxane (PDMS),
which has been widely used since 1989, for example, in
urology in the treatment of vesicoureteral reflux or stress
incontinence. As a suspension of textured silicone particles
with a mean particle diameter of 200 lm in a polyvinylpyr-
rolidone hydrogel, it can be injected with a 27-gauge needle
[1]. Since 1993 there have been sporadic reports about the
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use of PDMS for injection laryngoplasty in individual cases,
and later some instances of its use in the context of pro-
spective studies with a limited number of patients and
focusing on early postoperative results [1].
The aim of our study was to make a systematic analysis
of acoustic and perceptive voice parameters as well as
patients’ subjective assessment of PDMS used for injection
laryngoplasty on the basis of a larger number of patients
and with particular regard to long-term effects at least 12
months postoperatively. Long-term results are especially
important to rule out migration or foreign-body reactions.
Materials and methods
Twenty-one patients aged 41–86 years (mean = 62.4
years, standard deviation [SD] = 11.25 years) with
unilateral recurrent laryngeal nerve palsy underwent
injection laryngoplasty using PDMS elastomers between
March 2002 and August 2006. Table 1 gives detailed
information about the patients. The operation was per-
formed 5–161 months (mean = 43 months, SD = 82
months) after diagnosis of vocal cord paralysis. For
injection laryngoplasty VoxImplants (Bioplasty BV,
Geleen, The Netherlands) was used. Application was per-
formed during a direct laryngoscopy under general
anesthesia with jet ventilation or tracheal intubation using a
small tube. The substance was administered deeply lateral
to the thyroarytenoid muscle at a volume of 0.5–1.0 ml to
obtain a straight and midline vocal cord edge. Even though
the carrier material (polyvinylpyrrolidone) is resorbed,
according to the manufacturer’s product information the
injected volume of PDMS does not shrink. Therefore,
overinjection was strictly avoided.
Preoperatively, 6 weeks postoperatively, and at least 12
months (range = 12–27 months, mean = 18 months,
SD = 6 months) after injection laryngoplasty, the follow-
ing parameters of larynx and voice function were
measured: glottic closure by videolaryngostroboscopy,
maximum phonation time of the vowel /a/, and roughness,
breathiness, and hoarseness (RBH) using scores from 0 to 3
[4]. The acoustic analysis was performed by a voice range
profile: The voice range was measured in half-tones and
dynamic in dB calculated as the difference between the
loudest and the faintest tone of the phonetogram. Jitter,
shimmer, and noise-to-harmonic ratio (NHR) were
Table 1 List of patients
Patient
no.
Gender Age at
injection
(years)
Side Diagnosis/cause of paresis Preop voice
therapy
(No. sessions)
Postop voice
therapy
(No. sessions)
Latest control
(years after injection)
1 m 58 r Operation of cervical spine 20 3 2.3
2 m 67 l Bronchial carcinoma, pneumonectomy 15 0 Died
3 m 62 l Bronchial carcinoma, palliative 3 0 Died
4 m 60 l Esophageal carcinoma, surgery 24 6 1.9
5 m 59 l Bronchial carcinoma, pneumonectomy 10 0 1.6
6 m 51 l Esophageal carcinoma, surgery 10 0 1.9
7 m 76 l Cerebrovascular insult, central paresis 25 0 Died
8 m 41 l Brainstem glioma 21 0 1.6
9 m 53 r Esophageal carcinoma, surgery 7 0 Died
10 m 61 l Bronchial carcinoma, partial
pneumonectomy
7 7 1
11 f 47 r Idiopathic 37 0 1
12 m 52 l Aortic arch surgery 21 0 1.7
13 m 64 l Bronchial carcinoma, pneumonectomy 12 0 Died
14 m 66 l Bronchial carcinoma, palliative 4 0 Died
15 m 74 l Aortic arch surgery 16 7 1
16 m 58 l Idiopathic 12 0 1
17 m 63 r Esophageal carcinoma, surgery 0 0 1
18 m 72 l Aortic arch surgery 26 0 1
19 m 57 r Bronchial carcinoma, pneumonectomy 12 0 1
20 f 82 l Idiopathic 30 0 1
21 f 86 r Idiopathic 20 0 1
r = right; l = left; m = male; f = female
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calculated using MDVP (Multidimensional Voice Program,
Kay Elemetrics Corp., Lincoln Park, NJ, USA).
The subjective evaluation was carried out by the patient
answering a questionnaire containing four questions adapted
from the voice handicap index regarding their voice (3
questions for retired patients) to be answered on a six-step
scale (Table 2) [5]. The examination that was planned to be
held at least 12 months postoperatively has been carried out
in 15 patients. Meanwhile, six patients have died from the
palliative situation of their basic illness. Preoperatively, 20
patients had 3–37 lessons of voice therapy (mean = 15.6,
SD = 9.7); postoperatively, 4 patients had 3–7 more lessons
of voice therapy (mean = 1.2, SD = 2.5).
The prospective study was performed with the informed
consent of the patients and with the approval of the insti-
tutional review board.
Statistical evaluation was done using Wald-type, Hotell-
ing F-type, and ANOVA-type tests of the SAS software
(SAS Institute, Cary, NC, USA).
Results
Glottic closure during phonation
Glottic closure was incomplete in 20 patients preopera-
tively, and one patient showed a small dorsal insufficiency.
Six weeks after the operation complete glottic closure was
observed in 11 patients and a small dorsal insufficiency in 9
patients. One patient still showed glottic insufficiency. In
the 15 patients who have been examined 12 months after
their operation, 9 still showed complete glottic closure.
In six patients the dorsal gap remained unchanged
compared to the examination conducted 6 weeks after the
operation. Postoperative videolaryngostroboscopy, even 12
months postoperatively, did not indicate any migration or
granuloma formation.
Maximum phonation time
Maximum phonation time increased significantly 6 weeks
postoperatively (p \ 0.000005). A further significant increase
was observed during the first 12 months postoperatively
compared with the preoperative data (p = 0.00016) as well as
with the 6 weeks’ postoperative data (p = 0.03). The detailed
results are given in Table 3.
Roughness (R), breathiness (B), hoarseness (H)
Before the operation patients had very rough, breathy, and
hoarse voices. Six weeks after injection laryngoplasty, each
of the parameters—roughness, breathiness and hoarse-
ness—was significantly lower (p \ 0.000005 each). One
year after the operation the results remained significantly
better than before the operation (R: p = 0.00006, B:
p = 0.00002, H: p = 0.00006) and they remained
unchanged from the results 6 weeks after the operation (R:
p = 0.66, B: p = 0.10, H: p = 0.40). Details are shown in
Table 3. Figure 1 shows the relationship between hoarse-
ness and glottic closure.
Voice range, voice dynamic
Voice range increased significantly from a mean of 12.5
half-tones before the operation to 20.5 half-tones 6 weeks
after operation (p = 0.00001) and to 22.9 half-tones 12
Table 2 Questionnaire for subjective evaluation
1. Satisfaction: With my voice – as it is at the moment – I am
Very content Fairly content Moderately content Not very content Not content Not at all content
h h h h h h
6 5 4 3 2 1
2. Handicap in private life: My voice – as it is at the moment – handicaps me in private life
Not at all Only a little Moderately Quite a lot Greatly Very greatly
h h h h h h
6 5 4 3 2 1
3. Handicap in work life: My voice – as it is at the moment – handicaps me in work/professional life
Not at all Only a little Moderately Quite a lot Greatly Very greatly
h h h h h h
6 5 4 3 2 1
4. Liking: My voice – as it is at the moment – pleases me
Very much Quite a lot Moderately Not much Not Not at all
h h h h h h
6 5 4 3 2 1
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months after laryngoplasty (p = 0.0086). No significant
increase was found between the two postoperative exam-
inations (p = 0.60).
Voice dynamic increased significantly from a preoper-
ative mean of 14.5 dB to 24.6 dB 6 weeks after operation
(p \ 0.000005) and 26.0 dB after 12 months (p = 0.0094).
Both postoperative results showed no significant difference
(p = 0.74) (see details in Table 4).
Jitter, Shimmer, NHR
Both postoperative results of jitter were significantly lower
than before the operation (p = 0.00031 resp. p = 0.035).
No significant difference between the postoperative results
was found (p = 0.71).
Shimmer was significantly lower 6 weeks after laryn-
goplasty (p = 0.0011). Twelve months later the results
showed no significant difference compared to the preop-
erative results (p = 0.079).
NHR also showed a significant decrease only 6 weeks
after the operation (p = 0.00009) but not 12 months after
the operation (p = 0.063) (Table 4).
Subjective evaluation (self-assessment)
The question about the patient’s satisfaction with his or her
voice was answered preoperatively with ‘‘not very con-
tent.’’ Six weeks and one year after the operation theFig. 1 Influence of glottic closure on grade of hoarseness
Table 3 Maximum phonation time, RBH
Patient no. Maximum phonation time (s) Roughness (0–3) Breathiness (0–3) Hoarseness (0–3)
Preop 6 weeks
postop
12 months
postop
Preop 12 months
postop
preop 12 months
postop
Preop 12 months
postop
1 12 21 26 1 0 1 0 1 0
2 4 10 Died 2 Died 3 Died 3 Died
3 11 12 Died 3 Died 3 Died 3 Died
4 3 4 9 3 1 3 1 3 1
5 6 17 20 3 2 3 1 3 2
6 9 12 21 3 1 2 0 3 0
7 4 20 Died 3 Died 3 Died 3 Died
8 4 7 7 2 2 3 3 3 3
9 3 7 Died 3 Died 3 Died 3 Died
10 6 13 14 3 2 3 2 3 2
11 14 17 14 1 1 2 1 2 1
12 4 8 5 2 1 3 1 3 1
13 3 20 Died 3 Died 3 Died 3 Died
14 4 10 Died 3 Died 3 Died 3 Died
15 14 18 21 2 1 2 0 2 0
16 3 4 5 3 2 3 2 3 2
17 6 17 25 3 1 2 1 3 1
18 5 11 17 2 1 2 0 2 0
19 3 4 11 3 1 3 2 3 2
20 6 4 12 3 2 3 0 3 2
21 3 12 18 3 1 3 1 3 1
Mean 6.0 11.8 14.7 2.6 1.3 2.7 1.0 2.8 1.2
SD 3.7 5.7 8.3 0.7 0.6 0.6 0.9 0.5 0.9
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patients were ‘‘fairly content,’’ which is significantly better
(p \ 0.000005 resp. p \ 0.0092). The question about how
much handicap was experienced in private life was
answered preoperatively with ‘‘quite a lot.’’ Postopera-
tively it was ranked as ‘‘only a little,’’ which is significantly
better (p \ 0.000005 resp. p = 0.024). The question as to
how the patients liked their voice was answered as ‘‘not
much’’ before the operation and as ‘‘quite a lot,’’ which is
significantly better (p \ 0.000005 resp. p = 0.016). The
results for the patients asked about the handicap experi-
enced at work were significantly better after the operation
(p = 0.014 resp. 0.043) (for details see Table 5). Figure 2
shows the relation between patient satisfaction and glottic
closure.
Complications
During the 24 h of postoperative monitoring, no complica-
tions such as excessive pain, dyspnea, or dysphagia were
observed. Even during further observation, including endo-
scopic exams, no complications occurred such as foreign
body reaction or inflammation. Minimum postoperative
observation was 12 months, the longest 27 months
(mean = 18 months, SD = 6 months), excluding patients
who had meanwhile died from other diseases.
Discussion
Nowadays monitoring of the recurrent laryngeal nerve is
quite common in chest, esophageal, and thyroid gland
surgery, helping the surgeon to identify the nerve more
easily even in difficult situations [6]. But vocal fold
paralysis remains a typical complication in these fields of
surgery, be it accidentally or because there is a need to
resect lesions touching or even infiltrating the nerve. If
hoarseness occurs after surgery, putting the recurrent lar-
yngeal nerve at risk, the patient should be seen by an ENT
specialist within a few days for differential diagnosis of
vocal fold paralysis and vocal fold irritation caused by the
endolaryngeal tube from anesthesia. In case of paralysis,
voice therapy should be established within a few weeks.
Most patients in good general health, such as young
patients, who are undergoing thyroid gland surgery very
Table 4 Voice range and dynamic, jitter, shimmer, and noise-to-harmonic ratio
Patient no. Voice range (half tones) Voice dynamic (dB) Jitter (%) Shimmer (%) NHR
Preop 12 months
postop
Preop 12 months
postop
Preop 12 months
postop
Preop 12 months
postop
Preop 12 months
postop
1 22 25 23 22 5.2 1.5 29 9.4 0.60 0.19
2 3 Died 5 Died 20 Died 26 Died 1.2 Died
3 4 Died 10 Died 12 Died 17 Died 0.44 Died
4 23 25 22 29 5.0 1.3 13 4.8 0.22 0.13
5 19 20 24 26 2.3 7.3 13 26 0.23 0.79
6 14 30 9 27 1.9 0.73 14 3.7 0.30 0.14
7 11 Died 9 Died 6.5 Died 13 Died 0.40 Died
8 17 24 24 28 3.1 5.8 8.8 14 0.80 0.33
9 x Died x Died 9.8 Died 19 Died 0.70 Died
10 5 23 9 23 4.7 1.2 11 3.0 0.24 0.14
11 14 20 22 27 1.3 0.60 3.0 4.2 0.11 0.10
12 16 18 19 20 0.73 1.9 5.7 8.8 0.16 0.16
13 25 Died 19 Died 9.1 Died 13 Died 0.42 Died
14 10 Died 17 Died 4.9 Died 10 Died 0.31 Died
15 23 34 19 33 1.7 0.59 7.1 6.1 0.12 0.17
16 x 11 x 26 7.6 2.1 10 5.1 0.42 0.14
17 14 19 23 33 0.77 0.39 6.0 4.5 0.14 0.13
18 24 21 18 26 2.3 0.98 6.9 5.6 0.18 0.12
19 8 32 12 23 12 1.4 15 6.2 0.37 0.18
20 x 20 x 20 17 5.3 23 14 1.0 0.23
21 8 16 24 20 2.1 1.5 14 6.1 0.62 0.17
Mean 13.9 23 17 26 6.2 2.2 13 8.1 0.40 0.20
SD 7.5 6.1 6.1 4.2 5.4 2.1 6.7 5.9 0.30 0.17
x = too hoarse to be measured
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often succeed very well in achieving a compensatory
movement of the contralateral vocal cord. This may be why
in our group no patients who had undergone previous
thyroid gland surgery needed injection laryngoplasty.
However, in the case of patients whose condition is
generally poor, e.g., after surgery for bronchial carcinoma,
voice therapy is sometimes insufficient. In these patients
surgical treatment can improve voice quality. A very
common operation is thyroplasty which can be performed
under local anesthesia. This technique shows immediate
results during the operation giving the surgeon good con-
trol over how much to medialize the vocal fold. However,
this technique needs an external approach to the larynx and
requires the thyroid cartilage to be opened with a higher
risk of complications [7].
By contrast, injection laryngoplasty is performed endo-
laryngeally with no external approach which would lead to a
visible scar on the anterior neck. Because of the minimally
invasive character of injection laryngoplasty compared to
techniques using external approaches, the risk of infection is
expected to be lower. However, thyroplasty is the technique
of choice in patients with very severe glottic insufficiency, as
seen in lesions of the vagus nerve, because the paralyzed
vocal cord is then fixed in a more lateral position [8].
Since the first injection of paraffin oil into a paralyzed
vocal cord (as quoted in [1]), different materials have been
used for injection laryngoplasty. The ideal material should
be easy to administer, show good biocompatibility, should
Table 5 Subjective evaluation
Patient no. Satisfaction (1–6) Handicap in private life (1–6) Handicap in work life (1–6) Liking (1–6)
Preop 12 months
postop
Preop 12 months
postop
Preop 12 months
postop
Preop 12 months
postop
1 2 6 3 6 2 6 2 6
2 2 Died 2 Died 3 Died 3 Died
3 1 Died 3 Died 6 Died 2 Died
4 1 4 1 4 1 3 1 4
5 3 4 4 4 3 3 3 4
6 2 6 2 6 1 6 3 5
7 4 Died 3 Died x Died 3 Died
8 3 4 3 2 x x 2 1
9 4 Died 3 Died 2 Died 2 Died
10 3 5 5 5 3 6 3 4
11 3 6 4 5 3 5 3 6
12 4 5 4 5 4 5 4 4
13 4 Died 4 Died x x 4 Died
14 1 Died 1 Died x x 1 Died
15 1 5 2 6 1 6 2 5
16 4 4 2 3 x x 2 6
17 4 5 4 6 4 6 3 5
18 5 6 5 6 3 5 5 6
19 2 5 2 5 x x 2 6
20 1 4 1 4 1 4 1 5
21 2 4 2 5 2 4 4 6
Mean 2.7 4.8 2.9 4.8 2.6 4.9 2.6 4.9
SD 1.3 0.8 1.3 1.2 1.4 1.2 1.1 1.4
x = retired from work (due to age or illness)
Fig. 2 Influence of glottic closure on satisfaction
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not be pyrogenic, toxic, carcinogenic, allergenic, or
immunogenic, and it should be immobile and not resorb-
able. No material fulfilling all these criteria in an ideal way
yet exists [9]. Since all these substances produce a medi-
alization of the medial edge of the vocal folds, all of them
show comparably good short-term results. However,
because some of the substances used are slowly resorbed,
good initial results for these substances often disappear
after a few weeks or months, as described in more detail
below. Other compounds showing no resorption often
lacked biocompatibility, which led to chronic imflamma-
tion and granulomas, or over time slowly moved away
from the site of injection.
However, a good alternative is the PDMS used in this
study, which has been used in urology for therapy of ves-
icoureteral reflux since 1989 and for injection
laryngoplasty since 1993. Allergic reactions have not been
observed in animals [10] or in humans [11]. Due to its
minimum particle size of 100 lm, the PDMS elastomers
cannot be phagocytized, which means that the material
remains in place [1].
The results of this study indicate that a durable result
can be achieved with this substance, which does not change
significantly even after more than one year. Once achieved,
glottic closure during phonation as well as maximum
phonation time, voice range, voice dynamic, and the
parameters jitter, shimmer, and NHR remain stable at the
level achieved in long-term evaluation. Perceptive evalu-
ation of voice quality on the part of the examiner (RBH
classification) as well as the subjective evaluation on the
part of the patient (questionnaire) already show an
improvement shortly after the operation and this remains
unchanged during the investigation period of up to 27
months.
Paraffin oil, as injected by Bru¨ning, was soon abandoned
due to migration, foreign body reaction, rejection, and
recurrent inflammation [2]. Later in the 1950s the use of
biological materials was recommended by Arnold, but
autologous cartilage and bone flour appeared to be useless
because of their rapid resorption [12]. Bovine and autolo-
gous collagen are resorbed more slowly but nevertheless
almost completely; therefore, in addition to overcorrection
making the results unpredictable, a number of reinjections
were often necessary over time [1]. Even rare allergic
reactions have to be taken into account for these materials
[13]. Because of the risk of the transfection of prions which
has not yet been ruled out, bovine collagen should be used
with caution [14]. With respect to human collagen, the
published results are divergent. Pearl et al. [15]. report a
good subjective evaluation up to 3 months after injection of
human collagen despite laryngoscopic signs of resorption.
In contrast, Karpenko et al. [16] did not achieve an
improvement in subjective evaluation even though glottic
closure and maximum phonation time improved. Lundy
et al. [17] achieved short-term results for jitter, NHR, and
subjective evaluation 1 month after injection as good as
those that have been described for type I thyroplasty.
However, a methodical disadvantage of this study is the
lack of long-term results.
Another autologous material is fat tissue. It can most
often be harvested in abundance and its viscoelastic char-
acteristics are comparable to those of the vocal cord [2]. An
overcorrection is proposed because of its partial resorption,
but this is problematic because the rate of resorption differs
from patient to patient. According to a study by Shindo
et al. [18], resorption is observed especially during the first
6 months after the operation. In contrast, resorption has
been reported to be completely absent after overcorrection,
making surgical removal necessary [19].
Hyaluronan acid is resorbed to a smaller extent, which is
why, compared to collagen, the long-term results appear
somewhat better [20]. Hyaluronan acid is available either
as extract from rooster combs, so allergic reactions must be
taken into account [21], or as an antigen-free biotechno-
logic product. For the latter, foreign body reaction with the
formation of granulomas has been reported [21].
To solve the problem of resorption, Teflon has been
used since about 1960 and was at first regarded as the ideal
material for injection laryngoplasty. However, it was soon
observed that Teflon does not remain in place but
migrates, and it leads to chronic inflammation and granu-
lomas of the foreign body type. Therefore, nowadays the
use of Teflon is opposed [3].
In contrast to the partly resorbable biological substances
described above, the effect of PDMS is permanent, as has
been demonstrated by studies regarding its use in plastic
surgery [22]. Foreign body reactions, however, can be
imagined with the use PDMS. The immunologic response
is described as a ‘‘low-turnover foreign body response
without granuloma formation’’ [11]. The formation of
asymptomatic granulomas with the use of PDMS have been
described [23]. However, it has to be mentioned that in the
studies cited the granulomas occurred in the skin and
caused a cosmetic problem; the granulomas themselves did
not cause any other symptoms. Sittel et al. [1] did not
observe granulomas of the vocal cords of seven patients in
their long-term observation between 69 and 102 months
after operation. In our patients no such granulomas have
yet been observed; not even chronic inflammation has yet
occurred in our patients. It should be pointed out that
overcorrection, which may have unpredictable results, is
not needed in PDMS. The absence of resorbability of
PDMS described above has led to stable postoperative
results in our patients 1 year after injection laryngoplasty,
which remained unchanged from the results 6 weeks after
injection. In this context the unchanged subjective
1946 World J Surg (2008) 32:1940–1947
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evaluation of the patients regarding their satisfaction with
their voice after 1 year is especially important.
Conclusion
PDMS is a safe substance for injection laryngoplasty in
unilateral vocal cord paralysis. Objective and subjective
parameters confirm its effectiveness. It is suitable for
obtaining satisfying results in the reestablishment of the
patient’s voice and communication ability.
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